Hikal share news, announcements and annual reports
NSE: HIKALBSE: 524735Pharmaceuticals & BiotechnologySmall Cap
Hikal Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995 on BSE, Feb 2001 on NSE
Last close ₹211.58up ₹7.18 (3.51%)BSE ₹210.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹204.40.
30 Oct: open ₹205.88, high ₹223.70, low ₹204.72
52-week range of traded prices to 30 Oct 2026
₹146.25Low, 30 Mar 2026₹261.00High, 4 Dec 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,609 Cr1,090th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.28%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹76 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 3.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 40,73,4669.3% delivered
Hikal share news and announcements
726 announcements, routine notices left out, newest first. Page 14 of 15.
Aug 2010
Jul 2010
27 Jul · Meeting
Company's member's register and share transfer books will remain closed from August 11, 2010 to August 18, 2010 (both days inclusive) for the purpose of Annual General Meeting (which is scheduled to be held on August 18, 2010) and for payment of final dividend at the rate of Rs. 4/- per share (40%).13 Jul · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended June 30, 2010.
May 2010
6 May · Updates
Interim dividend for the year 2009-2010, on the equity shares will be paid on May 28, 2010.3 May · Corporate action
Company has fix the Record date for payment of Interim Dividend for the year 2009-10 as May 12, 2010.
Apr 2010
30 Apr · Dividend
Board of Directors of the Company at their meeting held on April 30, 2010 : (1) Declared interim dividend at the rate of Rs. 4/- per share (40%) on Equity Share Capital for the year ended March 31, 2010; (2) Recommended final dividend at the rate of Rs. 8/- per share (80%) on Equity Shares Capital for the year ended March 31, 2010, including Interim Dividend of Rs. 4/- per share (40%) on Equity Share Capital, subject to the approval of Shareholders in the ensuing Annual General Meeting.22 Apr · Board meeting
To consider and to take on record the Audited Financial Results and declaration / recommendation of dividend for the year ended March 31, 2010.
Feb 2010
9 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009 and year to date results for the period April 1, 2009 to December 31, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
15 Jan · Board meeting
Meeting on 23 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Nov 2009
24 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter and period ended September 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
14 Oct · Board meeting
Meeting on 22 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
15 Sep · Meeting
Minutes of the Annual General Meeting of the Company held on August 27, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
28 Aug · Meeting
Shareholders in the Annual General Meeting held on August 27, 2009 have appointed M/s. B S R & Company, Chartered Accountants, Mumbai, as Statutory Auditors of the Company in place of the Retiring Auditors M/s. Price Waterhouse, Chartered Accountants, to hold the office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company.14 Aug · Meeting
Notice of the Annual General Meeting of the Members of the Company to be held on August 27, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Meeting
Members' register and share transfer books will remain closed from August 20, 2009 to August 27, 2009 (both days inclusive) for the purpose of Annual General Meeting (which is scheduled to be held on August 27, 2009).
Jul 2009
31 Jul · Updates
Board of Directors at their meeting held on July 23, 2009, have proposed the name of B S R & Company, Chartered Accountants as the Statutory auditors of the company in place of Price Waterhouse, Chartered Accountants, to hold the office from the ensuing annual general meeting till the conclusion of the next annual general meeting of the company, subject to the approval of the shareholders at the ensuing annual general meeting of the company.15 Jul · Board meeting
Meeting on 23 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”6 Jul · Business
Honb'le High Court of Judicature at Bombay has approved the Scheme of Arrangement between Hikal Pharmaceuticals Ltd. and Hikal Ltd. and their respective Shareholders vide order dated June 25, 2009, a certified copy of which was made available on June 30, 2009. Further, certified copy of the order of the Hon'ble High Court of Judicature at Bombay sanctioning the Scheme from March 31, 2009 being Appointed Date, has been filed electronically with the Registrar of Companies, Maharashtra, Mumbai on June 30, 2009. Thus, the Scheme has become effective from June 30, 2009, being the date on which the said certified copy of the order sanctioning the Scheme passed by the High Court has been filed with the Registrar of Companies, Maharashtra, Mumbai. Accordingly, Hikal Pharmaceuticals Limited has been amalgamated with Hikal Limited and stands dissolved without being wound up
Jun 2009
30 Jun · Updates
Details as per requirement of clause 20 of the listing agreement.The details of the same shall be available on the NSE web site (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jun · Board meeting
To consider and to take on record the Audited Financial Results for the year ended March 31, 2009.
Apr 2009
9 Apr · Results
We will not be holding a Board Meeting for publishing the unaudited quarterly accounts within 1 (one) month of the expiry of the quarter ending 31st March, 2009. Instead we will be holding the Board Meeting before 30th June, 2009 for approval/publication of the audited results for the year ended 31st March, 2009
Mar 2009
26 Mar · Business
Board of Directors of the Company at there meeting held on March 25, 2009 considered and approved a Scheme of Arrangement which provides for merger of Hikal Pharmaceuticals Limited ('Hikal Pharm'), a wholly owned subsidiary of the Company with itself. The Appointed Date of the Scheme of Arrangement is March 25, 2009 i.e. the date of Board meeting approving the Scheme of Arrangement. The entire Equity Share Capital of Hikal Pharma is held by the Company and its nominees. Therefore, upon the Scheme becoming effective the entire equity share capital of Hikal Pharma will stand automatically cancelled and there will be no issue and allotment of shares pursuant to the Scheme.The Scheme of Amalgamation is, inter-alia, subject to the necessary approvals under the Companies Act, 1956 including the High Court of Bombay, or any other competent authority.23 Mar · Board meeting
For considering a proposal for merger of Hikal Pharmaceuticals Limited, a wholly owned subsidiary of the Company, with itself pursuant to a Scheme of Arrangement and all matters related and incidental thereto.
Feb 2009
12 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Feb · Disclosure
Disclosure in terms of Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997, in relation to the intimation received by the Company from Kalyani Steels Ltd., towards the pledge of shares of the Company by them. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
20 Jan · Board meeting
Board of Directors of the Company at their meeting held on January 20, 2009, has deferred the decision regarding declaration of Interim Dividend.12 Jan · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended December 31, 2008. In this meeting, the Board will also consider the declaration of Interim Dividend for the year 2008-2009.
Dec 2008
2 Dec · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
14 Oct · Board meeting
Meeting on 22 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Sep 2008
29 Sep · Allotment of Equity Shares
Share allotment committee of the Board of Directors of Hikal Ltd. in their meeting held on September 29, 2008, allotted 13,60,000 equity shares of Rs 10/- each at a premium of Rs.464/- per share to International Finance Corporation (IFC) aggregating Rs.6446.4 lacs. The said shares are subject to lock in for a period of one year from the date of allotment.11 Sep · Meeting
Minutes of the Annual General Meeting of the Company held on August 21, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Sep · Management
(i) Mr. Jai Hiremath, Chairman and Managing Director, has been re-appointed for a period of 5 years commencing July 01, 2008. (ii) Mr. Sameer Hiremath, Whole-time Director, has been re-appointed for a period of 5 years commencing July 01, 2008 and redesignated as Deputy Managing Director. These appointments were approved by the Shareholders in the Annual General Meeting held on August 21, 2008.
Aug 2008
28 Aug · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Aug · Dividend
Final dividend for the year 2007-2008 on the equity shares will be paid on September 10, 2008.7 Aug · Meeting
Minutes of Extra ordinary General Meeting of the shareholders of the Company held on July 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
29 Jul · Meeting
Members' register and share transfer books will remain closed from August 13, 2008 to August 21, 2008 (both days inclusive) for the purpose of Annual General Meeting which is scheduled to be held on August 21, 2008 and for payment of final dividend at the rate of Rs. 4.00 per share (40%).21 Jul · Management
In the meeting held on July 17, 2008, the Board has appointed Dr. Peter Pollak as an Additional Director w.e.f. July 17, 2008, u/s 260 of the Companies Act, 1956. Further, the Company has informed that Mr. Bimal Kishore Raizada has resigned from the Board of Directors of the Company w.e.f. July 17, 2008. For more details click here.8 Jul · Board meeting
Meeting on 17 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”8 Jul · Meeting
Notice of the Extraordinary General Meeting of the members of the Company scheduled to be held on July 30, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Business
Board of Directors at their meeting held on July 03, 2008 has subject to necessary approvals and applicable provisions of law, decided to issue upto 13,60,000 Equity shares of Rs.10/- each on preferential basis to International Finance Corporation (IFC) by investing upto Rs.64.46 crores, in compliance with Chapter XIII of SEBI (Disclosure and Investor Proctection) Guidelines 2000 and Companies Act, 1956.4 Jul · Updates
Information under clause 20(b). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jul · Dividend
Board of Directors of the Company at its meeting held on July 03, 2008 has recommended final dividend at the rate of Rs.4/- (Rupees four only) per share (40%) on Equity Share Capital for the year ended March 31, 2008, subject to the approval of Shareholders in the ensuing Annual General Meeting.
Jun 2008
30 Jun · Updates
Vide its letter dated June 30, 2008 that : Hikal has commissioned a new state-of-the-art multi purpose plant at Taloja, Dist. Raigad, Maharashtra to manufacture Active Ingredients for Crop Protection products, which was inaugurated by Dr. Wolfgang Welter, Member of the Board of Management of Bayer CropScience AG, today. The supplies will commence in the second half of the year. Hikal has entered into a long term contract manufacturing agreement with Bayer CropScience AG, Germany, one of the world's largest crop protection companies, for manufacture and supply of these products. Bayer CropScience AG is a subsidiary of Bayer AG, Germany which is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology.24 Jun · Board meeting
To consider and to take on record the Audited Financial Results and recommendation of final dividend for the year ended March 31, 2008.
May 2008
21 May · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended March 31, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
21 Apr · Board meeting
To consider and to take on record the Unaudited Financial Results for the quarter ended March 31, 2008.
Mar 2008
5 Mar · Updates
The Company has entered into a long term contract manufacturing agreement with Bayer CropScience AG Germany, one of the world's largest crop protection companies, for manufacture and supply of Active Ingredients for Crop Protection products. Buyer CropScience AG is a subsidiary of Bayer AG, Germany which is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. Hikal has set up a new state-of-the-art multi purpose plant at Taloja, Dist. Raigad, Maharastra to manufacture these products. Signing of this agreement will have substantial impact on the crop protection business of the company in coming years.